Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Acquisitions & Divestments (2020 - 2025)

Legend Biotech filings provide 6 years of Change in Acquisitions & Divestments readings, the most recent being $381.1 million for Q3 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 6.34% to $381.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.0 billion, a 29.16% increase, with the full-year FY2022 number at $483.6 million, up 168.68% from a year prior.
  • Change in Acquisitions & Divestments hit $381.1 million in Q3 2025 for Legend Biotech, down from $3.9 billion in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $3.9 billion in Q2 2025 to a low of $20.0 million in Q3 2021.
  • Median Change in Acquisitions & Divestments over the past 5 years was $336.0 million (2023), compared with a mean of $588.6 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 1125.82% in 2023 and later crashed 84.67% in 2024.
  • Legend Biotech's Change in Acquisitions & Divestments stood at $180.0 million in 2021, then skyrocketed by 168.68% to $483.6 million in 2022, then soared by 383.23% to $2.3 billion in 2023, then crashed by 84.67% to $358.4 million in 2024, then rose by 6.34% to $381.1 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $381.1 million (Q3 2025), $3.9 billion (Q2 2025), and $374.0 million (Q1 2025) per Business Quant data.